Department of Laboratory Medicine, Peking University International Hospital, Zhongguancun Life and Science Street NO.1, 102206, Beijing, People's Republic of China.
Center of Non-Infectious Liver Disease, the 5Th Medical Centre, Chinese PLA General Hospital, Beijing, 100039, People's Republic of China.
BMC Gastroenterol. 2024 Jan 2;24(1):2. doi: 10.1186/s12876-023-03103-9.
The influence of chronic hepatitis B infection (CBI) on hepatic steatosis, necroinflammation, and fibrosis in nonalcoholic fatty liver disease (NAFLD) population was unclear. We aimed to investigate the effect of CBI on hepatic steatosis and assess the association between NAFLD co-existed CBI and hepatic injury in NAFLD pediatric population.
Consecutive hospitalized children with biopsy-proven NAFLD with or without CBI were included. Hepatic steatosis, necroinflammation and fibrosis were evaluated by NASH CRN system and/or METAVIR scoring system, appropriately. Using multivariate logistic analysis, we identified variables associated with hepatic steatosis and liver injury.
Of 223 biopsy-proven NAFLD children, 161 were NAFLD without CBI, and 62 were NAFLD co-existed CBI. Grouped by mild, moderate and severe hepatic steatosis, there was an inverse association between CBI and the severity of hepatic steatosis [odd ratio (OR) 0.037, 95% confidence interval (CI) 0.014-0.098]. In addition, we explored the relationship between CBI and hepatic necroinflammation and fibrosis in NAFLD children. Hepatic necroinflammation and fibrosis, respectively, were divided into two groups according to severity. And CBI was positively associated with hepatic necroinflammation (OR 6.125, 95%CI 1.958-19.158). However, there was no statistically independent association between CBI and significant hepatic fibrosis.
CBI was inverse associated with the grade of steatosis and positively associated with severe hepatic necroinflammation, and does not appear to affect significant hepatic fibrosis in pediatric NAFLD children.
慢性乙型肝炎(CBI)感染对非酒精性脂肪性肝病(NAFLD)人群的肝脂肪变性、坏死性炎症和纤维化的影响尚不清楚。我们旨在研究 CBI 对肝脂肪变性的影响,并评估在儿童 NAFLD 人群中 CBI 合并 NAFLD 与肝损伤之间的关系。
纳入经肝活检证实的 CBI 合并或不合并 NAFLD 的连续住院患儿。通过 NASH CRN 系统和/或 METAVIR 评分系统适当评估肝脂肪变性、坏死性炎症和纤维化。使用多变量逻辑回归分析,我们确定了与肝脂肪变性和肝损伤相关的变量。
在 223 例经肝活检证实的 NAFLD 患儿中,161 例为无 CBI 的 NAFLD,62 例为 CBI 合并 NAFLD。根据轻度、中度和重度肝脂肪变性分组,CBI 与肝脂肪变性严重程度呈负相关[比值比(OR)0.037,95%置信区间(CI)0.014-0.098]。此外,我们还探讨了 CBI 与儿童 NAFLD 患者肝坏死性炎症和纤维化之间的关系。根据严重程度将肝坏死性炎症和纤维化分别分为两组。CBI 与肝坏死性炎症呈正相关(OR 6.125,95%CI 1.958-19.158)。然而,CBI 与显著肝纤维化之间没有统计学上的独立关联。
CBI 与脂肪变性程度呈负相关,与严重的肝坏死性炎症呈正相关,而在儿童 NAFLD 患者中似乎不影响显著的肝纤维化。